Monoclonal and Polyclonal Antibodies Research -- 专题文献

近5年高被引文献

Trends in peptide drug discovery

review Full Text OpenAlex 1472 FWCI34.665

Antibody drug conjugate: the “biological missile” for targeted cancer therapy

review Full Text OpenAlex 1061 FWCI43.858

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

article Full Text OpenAlex 900 FWCI57.097

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

article Full Text OpenAlex 884 FWCI124.154

Unlocking the potential of antibody–drug conjugates for cancer therapy

review Full Text OpenAlex 846 FWCI25.766

Translational Applications of Hydrogels

review Full Text OpenAlex 810 FWCI15.203

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

article Full Text OpenAlex 803 FWCI89.523

Teclistamab in Relapsed or Refractory Multiple Myeloma

article Full Text OpenAlex 760 FWCI160.275

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

article Full Text OpenAlex 739 FWCI82.362

Management of Rheumatoid Arthritis: An Overview

review Full Text OpenAlex 733 FWCI25.488

专题：Monoclonal and Polyclonal Antibodies Research

最新文献

Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial

Systemic Lupus Erythematosus

**Characterisation of the Novel HLA‐A68:326 and ‐C02:254N Alleles by Two Different Sequencing‐Based Typing Techniques**

Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy

**Identification of the Novel HLA‐DQA1*06:09 Allele**

**The Novel HLA‐DQB1*03:01:01:75 Allele Detected in a European Volunteer Bone Marrow Donor**

**HLA‐DQB1*03:19:01:03, A Novel Allele Discovered in a Greek Volunteer Bone Marrow Donor**

First-in-human study of JNJ-79635322 (JNJ-5322), a novel, next-generation trispecific antibody (TsAb), in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Initial phase 1 results.

Identification of the Novel HLA‐B Allele HLA‐B13:01:01:12* in Two Individuals From South India**

Precise targeting of HIV broadly neutralizing antibody precursors in humans

近5年高被引文献

Trends in peptide drug discovery

Antibody drug conjugate: the “biological missile” for targeted cancer therapy

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

Unlocking the potential of antibody–drug conjugates for cancer therapy

Translational Applications of Hydrogels

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

Teclistamab in Relapsed or Refractory Multiple Myeloma

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

Management of Rheumatoid Arthritis: An Overview

专题：Monoclonal and Polyclonal Antibodies Research

最新文献

Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial

Systemic Lupus Erythematosus

Characterisation of the Novel HLA‐A*68:326 and ‐C*02:254N Alleles by Two Different Sequencing‐Based Typing Techniques

Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy

Identification of the Novel HLA‐DQA1*06:09 Allele

The Novel HLA‐DQB1*03:01:01:75 Allele Detected in a European Volunteer Bone Marrow Donor

HLA‐DQB1*03:19:01:03, A Novel Allele Discovered in a Greek Volunteer Bone Marrow Donor

First-in-human study of JNJ-79635322 (JNJ-5322), a novel, next-generation trispecific antibody (TsAb), in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Initial phase 1 results.

Identification of the Novel HLA‐B Allele HLA‐B*13:01:01:12 in Two Individuals From South India

Precise targeting of HIV broadly neutralizing antibody precursors in humans

近5年高被引文献

Trends in peptide drug discovery

Antibody drug conjugate: the “biological missile” for targeted cancer therapy

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

Unlocking the potential of antibody–drug conjugates for cancer therapy

Translational Applications of Hydrogels

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

Teclistamab in Relapsed or Refractory Multiple Myeloma

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

Management of Rheumatoid Arthritis: An Overview

**Characterisation of the Novel HLA‐A68:326 and ‐C02:254N Alleles by Two Different Sequencing‐Based Typing Techniques**

**Identification of the Novel HLA‐DQA1*06:09 Allele**

**The Novel HLA‐DQB1*03:01:01:75 Allele Detected in a European Volunteer Bone Marrow Donor**

**HLA‐DQB1*03:19:01:03, A Novel Allele Discovered in a Greek Volunteer Bone Marrow Donor**

Identification of the Novel HLA‐B Allele HLA‐B13:01:01:12* in Two Individuals From South India**